TechnologyT2 · Outlet report
Laigo Bio closes €17M seed to advance SureTACs
This article was published on March 27, 2026 The Dutch biotech’s SureTACs platform targets membrane proteins that have long eluded conventional drug discovery by engineering them…
1 update1 source1 mention here
Mar 27, 2026
Latest: Laigo Bio closes €17M seed to advance SureTACs · The Next Web
